nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoxetate—ABCC3—Fluorouracil—colon cancer	0.14	0.164	CbGbCtD
Gadoxetate—ABCC3—Vincristine—colon cancer	0.127	0.149	CbGbCtD
Gadoxetate—ABCC4—Fluorouracil—colon cancer	0.107	0.125	CbGbCtD
Gadoxetate—ABCC3—Methotrexate—colon cancer	0.0771	0.0904	CbGbCtD
Gadoxetate—SLCO1B1—Irinotecan—colon cancer	0.0754	0.0884	CbGbCtD
Gadoxetate—SLCO1B3—Methotrexate—colon cancer	0.0685	0.0803	CbGbCtD
Gadoxetate—ABCC2—Irinotecan—colon cancer	0.0662	0.0776	CbGbCtD
Gadoxetate—ABCC4—Methotrexate—colon cancer	0.0589	0.0691	CbGbCtD
Gadoxetate—ABCC2—Vincristine—colon cancer	0.0579	0.0679	CbGbCtD
Gadoxetate—SLCO1B1—Methotrexate—colon cancer	0.0399	0.0468	CbGbCtD
Gadoxetate—ABCC2—Methotrexate—colon cancer	0.035	0.0411	CbGbCtD
Gadoxetate—ABCC2—bile—colon cancer	0.0081	0.281	CbGeAlD
Gadoxetate—ABCC3—gall bladder—colon cancer	0.00281	0.0978	CbGeAlD
Gadoxetate—SLCO1B3—vagina—colon cancer	0.00178	0.0619	CbGeAlD
Gadoxetate—SLCO1B3—liver—colon cancer	0.0015	0.0522	CbGeAlD
Gadoxetate—SLCO1B1—renal system—colon cancer	0.00142	0.0494	CbGeAlD
Gadoxetate—ABCC3—renal system—colon cancer	0.00135	0.0469	CbGeAlD
Gadoxetate—SLCO1B1—digestive system—colon cancer	0.00117	0.0406	CbGeAlD
Gadoxetate—ABCC4—renal system—colon cancer	0.00111	0.0387	CbGeAlD
Gadoxetate—ABCC3—digestive system—colon cancer	0.00111	0.0385	CbGeAlD
Gadoxetate—ABCC2—renal system—colon cancer	0.00108	0.0375	CbGeAlD
Gadoxetate—ABCC4—digestive system—colon cancer	0.000914	0.0318	CbGeAlD
Gadoxetate—ABCC2—digestive system—colon cancer	0.000885	0.0307	CbGeAlD
Gadoxetate—SLCO1B1—liver—colon cancer	0.000869	0.0302	CbGeAlD
Gadoxetate—ABCC4—bone marrow—colon cancer	0.000843	0.0293	CbGeAlD
Gadoxetate—ABCC3—liver—colon cancer	0.000825	0.0287	CbGeAlD
Gadoxetate—ABCC4—liver—colon cancer	0.000681	0.0237	CbGeAlD
Gadoxetate—ABCC2—liver—colon cancer	0.000659	0.0229	CbGeAlD
Gadoxetate—ABCC3—lymph node—colon cancer	0.000632	0.022	CbGeAlD
Gadoxetate—Abdominal distension—Irinotecan—colon cancer	0.00056	0.00481	CcSEcCtD
Gadoxetate—Abscess—Methotrexate—colon cancer	0.000558	0.0048	CcSEcCtD
Gadoxetate—Sweating increased—Irinotecan—colon cancer	0.000541	0.00465	CcSEcCtD
Gadoxetate—Dysphagia—Fluorouracil—colon cancer	0.000532	0.00458	CcSEcCtD
Gadoxetate—ABCC4—lymph node—colon cancer	0.000522	0.0181	CbGeAlD
Gadoxetate—Sepsis—Capecitabine—colon cancer	0.000515	0.00442	CcSEcCtD
Gadoxetate—Extravasation—Methotrexate—colon cancer	0.000506	0.00435	CcSEcCtD
Gadoxetate—ABCC2—lymph node—colon cancer	0.000505	0.0176	CbGeAlD
Gadoxetate—Acute coronary syndrome—Vincristine—colon cancer	0.000502	0.00431	CcSEcCtD
Gadoxetate—Phlebitis—Capecitabine—colon cancer	0.0005	0.00429	CcSEcCtD
Gadoxetate—Myocardial infarction—Vincristine—colon cancer	0.000499	0.00429	CcSEcCtD
Gadoxetate—Acute coronary syndrome—Irinotecan—colon cancer	0.000489	0.0042	CcSEcCtD
Gadoxetate—Swelling—Capecitabine—colon cancer	0.000488	0.00419	CcSEcCtD
Gadoxetate—Renal failure—Irinotecan—colon cancer	0.000487	0.00419	CcSEcCtD
Gadoxetate—Myocardial infarction—Irinotecan—colon cancer	0.000486	0.00418	CcSEcCtD
Gadoxetate—Oliguria—Methotrexate—colon cancer	0.000479	0.00412	CcSEcCtD
Gadoxetate—Acute coronary syndrome—Fluorouracil—colon cancer	0.000468	0.00402	CcSEcCtD
Gadoxetate—Ulcer—Methotrexate—colon cancer	0.000467	0.00401	CcSEcCtD
Gadoxetate—Renal failure acute—Capecitabine—colon cancer	0.000466	0.00401	CcSEcCtD
Gadoxetate—Myocardial infarction—Fluorouracil—colon cancer	0.000465	0.004	CcSEcCtD
Gadoxetate—Conjunctivitis—Fluorouracil—colon cancer	0.000461	0.00397	CcSEcCtD
Gadoxetate—Hypoaesthesia—Vincristine—colon cancer	0.000455	0.00391	CcSEcCtD
Gadoxetate—Renal impairment—Capecitabine—colon cancer	0.000452	0.00389	CcSEcCtD
Gadoxetate—Connective tissue disorder—Vincristine—colon cancer	0.000449	0.00386	CcSEcCtD
Gadoxetate—Rhinitis—Irinotecan—colon cancer	0.000446	0.00383	CcSEcCtD
Gadoxetate—Cerebrovascular accident—Capecitabine—colon cancer	0.000439	0.00378	CcSEcCtD
Gadoxetate—Connective tissue disorder—Irinotecan—colon cancer	0.000437	0.00376	CcSEcCtD
Gadoxetate—Rhinitis—Fluorouracil—colon cancer	0.000427	0.00367	CcSEcCtD
Gadoxetate—Cardiac disorder—Vincristine—colon cancer	0.000424	0.00364	CcSEcCtD
Gadoxetate—Hypoaesthesia—Fluorouracil—colon cancer	0.000424	0.00364	CcSEcCtD
Gadoxetate—Face oedema—Capecitabine—colon cancer	0.000416	0.00357	CcSEcCtD
Gadoxetate—Angiopathy—Vincristine—colon cancer	0.000414	0.00356	CcSEcCtD
Gadoxetate—Cardiac disorder—Irinotecan—colon cancer	0.000413	0.00355	CcSEcCtD
Gadoxetate—Flushing—Irinotecan—colon cancer	0.000413	0.00355	CcSEcCtD
Gadoxetate—Mediastinal disorder—Vincristine—colon cancer	0.000412	0.00354	CcSEcCtD
Gadoxetate—Irritability—Capecitabine—colon cancer	0.000411	0.00353	CcSEcCtD
Gadoxetate—Angiopathy—Irinotecan—colon cancer	0.000404	0.00347	CcSEcCtD
Gadoxetate—Blood creatinine increased—Capecitabine—colon cancer	0.000403	0.00347	CcSEcCtD
Gadoxetate—Immune system disorder—Irinotecan—colon cancer	0.000402	0.00345	CcSEcCtD
Gadoxetate—Mediastinal disorder—Irinotecan—colon cancer	0.000401	0.00345	CcSEcCtD
Gadoxetate—Dehydration—Capecitabine—colon cancer	0.0004	0.00344	CcSEcCtD
Gadoxetate—Chills—Irinotecan—colon cancer	0.000399	0.00343	CcSEcCtD
Gadoxetate—Arrhythmia—Irinotecan—colon cancer	0.000397	0.00342	CcSEcCtD
Gadoxetate—Hypokalaemia—Capecitabine—colon cancer	0.000392	0.00337	CcSEcCtD
Gadoxetate—Back pain—Vincristine—colon cancer	0.000385	0.00331	CcSEcCtD
Gadoxetate—Sepsis—Methotrexate—colon cancer	0.000383	0.00329	CcSEcCtD
Gadoxetate—Flatulence—Irinotecan—colon cancer	0.000382	0.00328	CcSEcCtD
Gadoxetate—Arrhythmia—Fluorouracil—colon cancer	0.000381	0.00327	CcSEcCtD
Gadoxetate—Back pain—Irinotecan—colon cancer	0.000375	0.00322	CcSEcCtD
Gadoxetate—Abdominal distension—Capecitabine—colon cancer	0.000375	0.00322	CcSEcCtD
Gadoxetate—Dysphagia—Capecitabine—colon cancer	0.000372	0.0032	CcSEcCtD
Gadoxetate—Bronchospasm—Capecitabine—colon cancer	0.000366	0.00315	CcSEcCtD
Gadoxetate—Agitation—Vincristine—colon cancer	0.000365	0.00314	CcSEcCtD
Gadoxetate—Sweating increased—Capecitabine—colon cancer	0.000362	0.00311	CcSEcCtD
Gadoxetate—Ill-defined disorder—Irinotecan—colon cancer	0.000359	0.00309	CcSEcCtD
Gadoxetate—Bronchitis—Capecitabine—colon cancer	0.000358	0.00308	CcSEcCtD
Gadoxetate—Vertigo—Vincristine—colon cancer	0.000357	0.00307	CcSEcCtD
Gadoxetate—Vision blurred—Fluorouracil—colon cancer	0.00035	0.003	CcSEcCtD
Gadoxetate—Malaise—Irinotecan—colon cancer	0.000349	0.003	CcSEcCtD
Gadoxetate—Vertigo—Irinotecan—colon cancer	0.000348	0.00299	CcSEcCtD
Gadoxetate—Syncope—Irinotecan—colon cancer	0.000347	0.00299	CcSEcCtD
Gadoxetate—Renal failure acute—Methotrexate—colon cancer	0.000347	0.00298	CcSEcCtD
Gadoxetate—Convulsion—Vincristine—colon cancer	0.000345	0.00296	CcSEcCtD
Gadoxetate—Loss of consciousness—Irinotecan—colon cancer	0.00034	0.00293	CcSEcCtD
Gadoxetate—Cough—Irinotecan—colon cancer	0.000338	0.0029	CcSEcCtD
Gadoxetate—Anaphylactoid reaction—Methotrexate—colon cancer	0.000331	0.00285	CcSEcCtD
Gadoxetate—Acute coronary syndrome—Capecitabine—colon cancer	0.000327	0.00281	CcSEcCtD
Gadoxetate—Cerebrovascular accident—Methotrexate—colon cancer	0.000327	0.00281	CcSEcCtD
Gadoxetate—Renal failure—Capecitabine—colon cancer	0.000326	0.0028	CcSEcCtD
Gadoxetate—Discomfort—Irinotecan—colon cancer	0.000326	0.0028	CcSEcCtD
Gadoxetate—Myocardial infarction—Capecitabine—colon cancer	0.000325	0.00279	CcSEcCtD
Gadoxetate—Anaphylactic shock—Vincristine—colon cancer	0.000325	0.00279	CcSEcCtD
Gadoxetate—Oedema—Vincristine—colon cancer	0.000325	0.00279	CcSEcCtD
Gadoxetate—Infection—Vincristine—colon cancer	0.000322	0.00277	CcSEcCtD
Gadoxetate—Conjunctivitis—Capecitabine—colon cancer	0.000322	0.00277	CcSEcCtD
Gadoxetate—Convulsion—Fluorouracil—colon cancer	0.000321	0.00276	CcSEcCtD
Gadoxetate—Nervous system disorder—Vincristine—colon cancer	0.000318	0.00274	CcSEcCtD
Gadoxetate—Oedema—Irinotecan—colon cancer	0.000316	0.00272	CcSEcCtD
Gadoxetate—Anaphylactic shock—Irinotecan—colon cancer	0.000316	0.00272	CcSEcCtD
Gadoxetate—Chest pain—Fluorouracil—colon cancer	0.000316	0.00271	CcSEcCtD
Gadoxetate—Infection—Irinotecan—colon cancer	0.000314	0.0027	CcSEcCtD
Gadoxetate—Hyperhidrosis—Vincristine—colon cancer	0.000314	0.0027	CcSEcCtD
Gadoxetate—Discomfort—Fluorouracil—colon cancer	0.000312	0.00268	CcSEcCtD
Gadoxetate—Shock—Irinotecan—colon cancer	0.000311	0.00267	CcSEcCtD
Gadoxetate—Nervous system disorder—Irinotecan—colon cancer	0.00031	0.00266	CcSEcCtD
Gadoxetate—Anorexia—Vincristine—colon cancer	0.000309	0.00266	CcSEcCtD
Gadoxetate—Irritability—Methotrexate—colon cancer	0.000306	0.00263	CcSEcCtD
Gadoxetate—Hyperhidrosis—Irinotecan—colon cancer	0.000306	0.00263	CcSEcCtD
Gadoxetate—Hypotension—Vincristine—colon cancer	0.000303	0.00261	CcSEcCtD
Gadoxetate—Oedema—Fluorouracil—colon cancer	0.000303	0.0026	CcSEcCtD
Gadoxetate—Anaphylactic shock—Fluorouracil—colon cancer	0.000303	0.0026	CcSEcCtD
Gadoxetate—Anorexia—Irinotecan—colon cancer	0.000301	0.00259	CcSEcCtD
Gadoxetate—Infection—Fluorouracil—colon cancer	0.000301	0.00259	CcSEcCtD
Gadoxetate—Rhinitis—Capecitabine—colon cancer	0.000299	0.00257	CcSEcCtD
Gadoxetate—Nervous system disorder—Fluorouracil—colon cancer	0.000297	0.00255	CcSEcCtD
Gadoxetate—Hypoaesthesia—Capecitabine—colon cancer	0.000296	0.00255	CcSEcCtD
Gadoxetate—Tachycardia—Fluorouracil—colon cancer	0.000295	0.00254	CcSEcCtD
Gadoxetate—Hypotension—Irinotecan—colon cancer	0.000295	0.00254	CcSEcCtD
Gadoxetate—Connective tissue disorder—Capecitabine—colon cancer	0.000293	0.00252	CcSEcCtD
Gadoxetate—Paraesthesia—Vincristine—colon cancer	0.000291	0.00251	CcSEcCtD
Gadoxetate—Anorexia—Fluorouracil—colon cancer	0.000289	0.00248	CcSEcCtD
Gadoxetate—Paraesthesia—Irinotecan—colon cancer	0.000284	0.00244	CcSEcCtD
Gadoxetate—Hypotension—Fluorouracil—colon cancer	0.000283	0.00243	CcSEcCtD
Gadoxetate—Decreased appetite—Vincristine—colon cancer	0.000282	0.00243	CcSEcCtD
Gadoxetate—Dyspnoea—Irinotecan—colon cancer	0.000282	0.00242	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Vincristine—colon cancer	0.00028	0.00241	CcSEcCtD
Gadoxetate—Fatigue—Vincristine—colon cancer	0.00028	0.00241	CcSEcCtD
Gadoxetate—Constipation—Vincristine—colon cancer	0.000278	0.00239	CcSEcCtD
Gadoxetate—Cardiac disorder—Capecitabine—colon cancer	0.000276	0.00238	CcSEcCtD
Gadoxetate—Flushing—Capecitabine—colon cancer	0.000276	0.00238	CcSEcCtD
Gadoxetate—Decreased appetite—Irinotecan—colon cancer	0.000275	0.00236	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Irinotecan—colon cancer	0.000273	0.00235	CcSEcCtD
Gadoxetate—Fatigue—Irinotecan—colon cancer	0.000273	0.00234	CcSEcCtD
Gadoxetate—Paraesthesia—Fluorouracil—colon cancer	0.000272	0.00234	CcSEcCtD
Gadoxetate—Constipation—Irinotecan—colon cancer	0.00027	0.00232	CcSEcCtD
Gadoxetate—Angiopathy—Capecitabine—colon cancer	0.00027	0.00232	CcSEcCtD
Gadoxetate—Dyspnoea—Fluorouracil—colon cancer	0.00027	0.00232	CcSEcCtD
Gadoxetate—Immune system disorder—Capecitabine—colon cancer	0.000269	0.00231	CcSEcCtD
Gadoxetate—Mediastinal disorder—Capecitabine—colon cancer	0.000268	0.00231	CcSEcCtD
Gadoxetate—Chills—Capecitabine—colon cancer	0.000267	0.0023	CcSEcCtD
Gadoxetate—Arrhythmia—Capecitabine—colon cancer	0.000266	0.00229	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Vincristine—colon cancer	0.000265	0.00228	CcSEcCtD
Gadoxetate—Decreased appetite—Fluorouracil—colon cancer	0.000263	0.00226	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000261	0.00225	CcSEcCtD
Gadoxetate—Feeling abnormal—Irinotecan—colon cancer	0.00026	0.00224	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Irinotecan—colon cancer	0.000258	0.00222	CcSEcCtD
Gadoxetate—Abdominal pain—Vincristine—colon cancer	0.000257	0.00221	CcSEcCtD
Gadoxetate—Body temperature increased—Vincristine—colon cancer	0.000257	0.00221	CcSEcCtD
Gadoxetate—Flatulence—Capecitabine—colon cancer	0.000255	0.0022	CcSEcCtD
Gadoxetate—Dysgeusia—Capecitabine—colon cancer	0.000254	0.00218	CcSEcCtD
Gadoxetate—Back pain—Capecitabine—colon cancer	0.000251	0.00216	CcSEcCtD
Gadoxetate—Abdominal pain—Irinotecan—colon cancer	0.00025	0.00215	CcSEcCtD
Gadoxetate—Body temperature increased—Irinotecan—colon cancer	0.00025	0.00215	CcSEcCtD
Gadoxetate—Feeling abnormal—Fluorouracil—colon cancer	0.000249	0.00214	CcSEcCtD
Gadoxetate—Vision blurred—Capecitabine—colon cancer	0.000244	0.0021	CcSEcCtD
Gadoxetate—Tremor—Capecitabine—colon cancer	0.000243	0.00209	CcSEcCtD
Gadoxetate—Renal failure—Methotrexate—colon cancer	0.000243	0.00209	CcSEcCtD
Gadoxetate—Ill-defined disorder—Capecitabine—colon cancer	0.000241	0.00207	CcSEcCtD
Gadoxetate—Urticaria—Fluorouracil—colon cancer	0.000241	0.00207	CcSEcCtD
Gadoxetate—Conjunctivitis—Methotrexate—colon cancer	0.00024	0.00206	CcSEcCtD
Gadoxetate—Body temperature increased—Fluorouracil—colon cancer	0.000239	0.00206	CcSEcCtD
Gadoxetate—Hypersensitivity—Vincristine—colon cancer	0.000239	0.00206	CcSEcCtD
Gadoxetate—Malaise—Capecitabine—colon cancer	0.000234	0.00201	CcSEcCtD
Gadoxetate—Vertigo—Capecitabine—colon cancer	0.000233	0.002	CcSEcCtD
Gadoxetate—Hypersensitivity—Irinotecan—colon cancer	0.000233	0.002	CcSEcCtD
Gadoxetate—Asthenia—Vincristine—colon cancer	0.000233	0.002	CcSEcCtD
Gadoxetate—Syncope—Capecitabine—colon cancer	0.000232	0.002	CcSEcCtD
Gadoxetate—Palpitations—Capecitabine—colon cancer	0.000229	0.00197	CcSEcCtD
Gadoxetate—Loss of consciousness—Capecitabine—colon cancer	0.000228	0.00196	CcSEcCtD
Gadoxetate—Asthenia—Irinotecan—colon cancer	0.000227	0.00195	CcSEcCtD
Gadoxetate—Cough—Capecitabine—colon cancer	0.000226	0.00194	CcSEcCtD
Gadoxetate—Hypersensitivity—Fluorouracil—colon cancer	0.000223	0.00192	CcSEcCtD
Gadoxetate—Diarrhoea—Vincristine—colon cancer	0.000222	0.00191	CcSEcCtD
Gadoxetate—Chest pain—Capecitabine—colon cancer	0.000221	0.0019	CcSEcCtD
Gadoxetate—Anxiety—Capecitabine—colon cancer	0.00022	0.00189	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000219	0.00188	CcSEcCtD
Gadoxetate—Discomfort—Capecitabine—colon cancer	0.000218	0.00187	CcSEcCtD
Gadoxetate—Diarrhoea—Irinotecan—colon cancer	0.000216	0.00186	CcSEcCtD
Gadoxetate—Dry mouth—Capecitabine—colon cancer	0.000216	0.00186	CcSEcCtD
Gadoxetate—Dizziness—Vincristine—colon cancer	0.000215	0.00184	CcSEcCtD
Gadoxetate—Pruritus—Fluorouracil—colon cancer	0.000214	0.00184	CcSEcCtD
Gadoxetate—Oedema—Capecitabine—colon cancer	0.000212	0.00182	CcSEcCtD
Gadoxetate—Infection—Capecitabine—colon cancer	0.00021	0.00181	CcSEcCtD
Gadoxetate—ABCC3—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.000209	0.0989	CbGpPWpGaD
Gadoxetate—Dizziness—Irinotecan—colon cancer	0.000209	0.0018	CcSEcCtD
Gadoxetate—Shock—Capecitabine—colon cancer	0.000208	0.00179	CcSEcCtD
Gadoxetate—Nervous system disorder—Capecitabine—colon cancer	0.000207	0.00178	CcSEcCtD
Gadoxetate—Diarrhoea—Fluorouracil—colon cancer	0.000207	0.00178	CcSEcCtD
Gadoxetate—Tachycardia—Capecitabine—colon cancer	0.000206	0.00177	CcSEcCtD
Gadoxetate—Vomiting—Vincristine—colon cancer	0.000206	0.00177	CcSEcCtD
Gadoxetate—Cardiac disorder—Methotrexate—colon cancer	0.000206	0.00177	CcSEcCtD
Gadoxetate—Skin disorder—Capecitabine—colon cancer	0.000205	0.00177	CcSEcCtD
Gadoxetate—Rash—Vincristine—colon cancer	0.000205	0.00176	CcSEcCtD
Gadoxetate—Hyperhidrosis—Capecitabine—colon cancer	0.000205	0.00176	CcSEcCtD
Gadoxetate—Dermatitis—Vincristine—colon cancer	0.000204	0.00176	CcSEcCtD
Gadoxetate—Headache—Vincristine—colon cancer	0.000203	0.00175	CcSEcCtD
Gadoxetate—Anorexia—Capecitabine—colon cancer	0.000202	0.00173	CcSEcCtD
Gadoxetate—Angiopathy—Methotrexate—colon cancer	0.000201	0.00173	CcSEcCtD
Gadoxetate—Vomiting—Irinotecan—colon cancer	0.000201	0.00173	CcSEcCtD
Gadoxetate—Immune system disorder—Methotrexate—colon cancer	0.0002	0.00172	CcSEcCtD
Gadoxetate—Dizziness—Fluorouracil—colon cancer	0.0002	0.00172	CcSEcCtD
Gadoxetate—Mediastinal disorder—Methotrexate—colon cancer	0.0002	0.00172	CcSEcCtD
Gadoxetate—Rash—Irinotecan—colon cancer	0.000199	0.00171	CcSEcCtD
Gadoxetate—Dermatitis—Irinotecan—colon cancer	0.000199	0.00171	CcSEcCtD
Gadoxetate—Chills—Methotrexate—colon cancer	0.000199	0.00171	CcSEcCtD
Gadoxetate—Headache—Irinotecan—colon cancer	0.000198	0.0017	CcSEcCtD
Gadoxetate—Hypotension—Capecitabine—colon cancer	0.000198	0.0017	CcSEcCtD
Gadoxetate—Nausea—Vincristine—colon cancer	0.000193	0.00166	CcSEcCtD
Gadoxetate—Vomiting—Fluorouracil—colon cancer	0.000192	0.00165	CcSEcCtD
Gadoxetate—Rash—Fluorouracil—colon cancer	0.000191	0.00164	CcSEcCtD
Gadoxetate—Dermatitis—Fluorouracil—colon cancer	0.000191	0.00164	CcSEcCtD
Gadoxetate—Paraesthesia—Capecitabine—colon cancer	0.00019	0.00163	CcSEcCtD
Gadoxetate—Headache—Fluorouracil—colon cancer	0.00019	0.00163	CcSEcCtD
Gadoxetate—Dysgeusia—Methotrexate—colon cancer	0.000189	0.00162	CcSEcCtD
Gadoxetate—Dyspnoea—Capecitabine—colon cancer	0.000189	0.00162	CcSEcCtD
Gadoxetate—Nausea—Irinotecan—colon cancer	0.000188	0.00161	CcSEcCtD
Gadoxetate—Back pain—Methotrexate—colon cancer	0.000187	0.0016	CcSEcCtD
Gadoxetate—Decreased appetite—Capecitabine—colon cancer	0.000184	0.00158	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Capecitabine—colon cancer	0.000183	0.00157	CcSEcCtD
Gadoxetate—Fatigue—Capecitabine—colon cancer	0.000182	0.00157	CcSEcCtD
Gadoxetate—Vision blurred—Methotrexate—colon cancer	0.000182	0.00156	CcSEcCtD
Gadoxetate—Constipation—Capecitabine—colon cancer	0.000181	0.00155	CcSEcCtD
Gadoxetate—Nausea—Fluorouracil—colon cancer	0.00018	0.00155	CcSEcCtD
Gadoxetate—Ill-defined disorder—Methotrexate—colon cancer	0.000179	0.00154	CcSEcCtD
Gadoxetate—Feeling abnormal—Capecitabine—colon cancer	0.000174	0.0015	CcSEcCtD
Gadoxetate—Malaise—Methotrexate—colon cancer	0.000174	0.0015	CcSEcCtD
Gadoxetate—Vertigo—Methotrexate—colon cancer	0.000173	0.00149	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Capecitabine—colon cancer	0.000173	0.00149	CcSEcCtD
Gadoxetate—Cough—Methotrexate—colon cancer	0.000168	0.00145	CcSEcCtD
Gadoxetate—Urticaria—Capecitabine—colon cancer	0.000168	0.00144	CcSEcCtD
Gadoxetate—Abdominal pain—Capecitabine—colon cancer	0.000167	0.00144	CcSEcCtD
Gadoxetate—Body temperature increased—Capecitabine—colon cancer	0.000167	0.00144	CcSEcCtD
Gadoxetate—Convulsion—Methotrexate—colon cancer	0.000167	0.00144	CcSEcCtD
Gadoxetate—ABCC2—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.000166	0.0784	CbGpPWpGaD
Gadoxetate—Chest pain—Methotrexate—colon cancer	0.000164	0.00141	CcSEcCtD
Gadoxetate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000163	0.0014	CcSEcCtD
Gadoxetate—Discomfort—Methotrexate—colon cancer	0.000162	0.0014	CcSEcCtD
Gadoxetate—Anaphylactic shock—Methotrexate—colon cancer	0.000157	0.00135	CcSEcCtD
Gadoxetate—Infection—Methotrexate—colon cancer	0.000156	0.00134	CcSEcCtD
Gadoxetate—Hypersensitivity—Capecitabine—colon cancer	0.000156	0.00134	CcSEcCtD
Gadoxetate—SLCO1B1—Codeine and Morphine Metabolism—ABCB1—colon cancer	0.000156	0.0736	CbGpPWpGaD
Gadoxetate—Nervous system disorder—Methotrexate—colon cancer	0.000154	0.00133	CcSEcCtD
Gadoxetate—Skin disorder—Methotrexate—colon cancer	0.000153	0.00131	CcSEcCtD
Gadoxetate—Hyperhidrosis—Methotrexate—colon cancer	0.000152	0.00131	CcSEcCtD
Gadoxetate—Asthenia—Capecitabine—colon cancer	0.000152	0.0013	CcSEcCtD
Gadoxetate—Anorexia—Methotrexate—colon cancer	0.00015	0.00129	CcSEcCtD
Gadoxetate—Pruritus—Capecitabine—colon cancer	0.00015	0.00129	CcSEcCtD
Gadoxetate—Hypotension—Methotrexate—colon cancer	0.000147	0.00126	CcSEcCtD
Gadoxetate—Diarrhoea—Capecitabine—colon cancer	0.000145	0.00124	CcSEcCtD
Gadoxetate—Paraesthesia—Methotrexate—colon cancer	0.000141	0.00122	CcSEcCtD
Gadoxetate—Dyspnoea—Methotrexate—colon cancer	0.00014	0.00121	CcSEcCtD
Gadoxetate—Dizziness—Capecitabine—colon cancer	0.00014	0.0012	CcSEcCtD
Gadoxetate—Decreased appetite—Methotrexate—colon cancer	0.000137	0.00118	CcSEcCtD
Gadoxetate—Gastrointestinal disorder—Methotrexate—colon cancer	0.000136	0.00117	CcSEcCtD
Gadoxetate—Fatigue—Methotrexate—colon cancer	0.000136	0.00117	CcSEcCtD
Gadoxetate—Vomiting—Capecitabine—colon cancer	0.000135	0.00116	CcSEcCtD
Gadoxetate—Rash—Capecitabine—colon cancer	0.000133	0.00115	CcSEcCtD
Gadoxetate—Dermatitis—Capecitabine—colon cancer	0.000133	0.00115	CcSEcCtD
Gadoxetate—Headache—Capecitabine—colon cancer	0.000133	0.00114	CcSEcCtD
Gadoxetate—Feeling abnormal—Methotrexate—colon cancer	0.00013	0.00112	CcSEcCtD
Gadoxetate—Gastrointestinal pain—Methotrexate—colon cancer	0.000129	0.00111	CcSEcCtD
Gadoxetate—Nausea—Capecitabine—colon cancer	0.000126	0.00108	CcSEcCtD
Gadoxetate—Urticaria—Methotrexate—colon cancer	0.000125	0.00108	CcSEcCtD
Gadoxetate—Abdominal pain—Methotrexate—colon cancer	0.000124	0.00107	CcSEcCtD
Gadoxetate—Body temperature increased—Methotrexate—colon cancer	0.000124	0.00107	CcSEcCtD
Gadoxetate—Hypersensitivity—Methotrexate—colon cancer	0.000116	0.000997	CcSEcCtD
Gadoxetate—ABCC3—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.000114	0.0541	CbGpPWpGaD
Gadoxetate—Asthenia—Methotrexate—colon cancer	0.000113	0.000971	CcSEcCtD
Gadoxetate—Pruritus—Methotrexate—colon cancer	0.000111	0.000958	CcSEcCtD
Gadoxetate—Diarrhoea—Methotrexate—colon cancer	0.000108	0.000926	CcSEcCtD
Gadoxetate—ABCC4—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	0.000108	0.0509	CbGpPWpGaD
Gadoxetate—Dizziness—Methotrexate—colon cancer	0.000104	0.000895	CcSEcCtD
Gadoxetate—Vomiting—Methotrexate—colon cancer	0.0001	0.000861	CcSEcCtD
Gadoxetate—Rash—Methotrexate—colon cancer	9.93e-05	0.000853	CcSEcCtD
Gadoxetate—Dermatitis—Methotrexate—colon cancer	9.92e-05	0.000853	CcSEcCtD
Gadoxetate—Headache—Methotrexate—colon cancer	9.87e-05	0.000848	CcSEcCtD
Gadoxetate—Nausea—Methotrexate—colon cancer	9.35e-05	0.000804	CcSEcCtD
Gadoxetate—ABCC2—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	9.08e-05	0.0429	CbGpPWpGaD
Gadoxetate—SLCO1B1—Drug Induction of Bile Acid Pathway—ABCB1—colon cancer	8.52e-05	0.0403	CbGpPWpGaD
Gadoxetate—ABCC2—Irinotecan Pathway—APC—colon cancer	7.64e-05	0.0361	CbGpPWpGaD
Gadoxetate—SLCO1B1—Irinotecan Pathway—APC—colon cancer	7.18e-05	0.0339	CbGpPWpGaD
Gadoxetate—ABCC3—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	6.9e-05	0.0326	CbGpPWpGaD
Gadoxetate—ABCC3—Fluoropyrimidine Activity—TYMS—colon cancer	6.61e-05	0.0313	CbGpPWpGaD
Gadoxetate—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	6.57e-05	0.0311	CbGpPWpGaD
Gadoxetate—ABCC3—ABC-family proteins mediated transport—ABCB1—colon cancer	6.28e-05	0.0297	CbGpPWpGaD
Gadoxetate—ABCC4—Fluoropyrimidine Activity—TYMS—colon cancer	6.22e-05	0.0294	CbGpPWpGaD
Gadoxetate—ABCC4—ABC-family proteins mediated transport—ABCB1—colon cancer	5.91e-05	0.0279	CbGpPWpGaD
Gadoxetate—ABCC2—Constitutive Androstane Receptor Pathway—ABCB1—colon cancer	5.47e-05	0.0259	CbGpPWpGaD
Gadoxetate—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—colon cancer	5.21e-05	0.0246	CbGpPWpGaD
Gadoxetate—ABCC2—ABC-family proteins mediated transport—ABCB1—colon cancer	4.98e-05	0.0235	CbGpPWpGaD
Gadoxetate—ABCC3—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	4.57e-05	0.0216	CbGpPWpGaD
Gadoxetate—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—colon cancer	3.63e-05	0.0171	CbGpPWpGaD
Gadoxetate—ABCC3—Fluoropyrimidine Activity—TP53—colon cancer	2.19e-05	0.0104	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CA7—colon cancer	2.13e-05	0.0101	CbGpPWpGaD
Gadoxetate—ABCC4—Fluoropyrimidine Activity—TP53—colon cancer	2.06e-05	0.00975	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CA7—colon cancer	1.92e-05	0.00907	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CA7—colon cancer	1.43e-05	0.00676	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet degranulation—VEGFA—colon cancer	1.34e-05	0.00635	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—CHST5—colon cancer	1.29e-05	0.00609	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ODC1—colon cancer	1.29e-05	0.00609	CbGpPWpGaD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—colon cancer	1.28e-05	0.00605	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet degranulation—TGFB1—colon cancer	1.23e-05	0.00583	CbGpPWpGaD
Gadoxetate—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—colon cancer	1.18e-05	0.00555	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—CHST5—colon cancer	1.16e-05	0.0055	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ODC1—colon cancer	1.16e-05	0.0055	CbGpPWpGaD
Gadoxetate—ABCC4—Ectoderm Differentiation—CTNNB1—colon cancer	9.87e-06	0.00466	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ODC1—colon cancer	8.66e-06	0.00409	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—CHST5—colon cancer	8.66e-06	0.00409	CbGpPWpGaD
Gadoxetate—ABCC3—NRF2 pathway—TGFB1—colon cancer	8.11e-06	0.00383	CbGpPWpGaD
Gadoxetate—ABCC4—Ectoderm Differentiation—MYC—colon cancer	7.99e-06	0.00378	CbGpPWpGaD
Gadoxetate—ABCC4—NRF2 pathway—TGFB1—colon cancer	7.62e-06	0.0036	CbGpPWpGaD
Gadoxetate—SLCO1B3—Transmembrane transport of small molecules—ABCB1—colon cancer	7.27e-06	0.00344	CbGpPWpGaD
Gadoxetate—ABCC3—Transmembrane transport of small molecules—ABCB1—colon cancer	6.56e-06	0.0031	CbGpPWpGaD
Gadoxetate—ABCC2—NRF2 pathway—TGFB1—colon cancer	6.43e-06	0.00304	CbGpPWpGaD
Gadoxetate—ABCC4—Transmembrane transport of small molecules—ABCB1—colon cancer	6.17e-06	0.00292	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—SRC—colon cancer	6.12e-06	0.00289	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—VEGFA—colon cancer	5.96e-06	0.00282	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—TGFB1—colon cancer	5.47e-06	0.00259	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—colon cancer	5.32e-06	0.00252	CbGpPWpGaD
Gadoxetate—ABCC2—Transmembrane transport of small molecules—ABCB1—colon cancer	5.2e-06	0.00246	CbGpPWpGaD
Gadoxetate—SLCO1B1—Transmembrane transport of small molecules—ABCB1—colon cancer	4.89e-06	0.00231	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.8e-06	0.00227	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—PIK3CA—colon cancer	4.66e-06	0.0022	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	4.19e-06	0.00198	CbGpPWpGaD
Gadoxetate—ABCC4—Platelet activation, signaling and aggregation—AKT1—colon cancer	3.8e-06	0.0018	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.78e-06	0.00179	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	3.58e-06	0.00169	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.48e-06	0.00165	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—ABCB1—colon cancer	3.41e-06	0.00161	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—TYMS—colon cancer	3.35e-06	0.00158	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—EP300—colon cancer	3.24e-06	0.00153	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—SRC—colon cancer	3.15e-06	0.00149	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.14e-06	0.00148	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—ABCB1—colon cancer	3.07e-06	0.00145	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—VEGFA—colon cancer	3.07e-06	0.00145	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—NRAS—colon cancer	3.04e-06	0.00143	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—TYMS—colon cancer	3.02e-06	0.00143	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—TGFB1—colon cancer	2.82e-06	0.00133	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.81e-06	0.00133	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—KRAS—colon cancer	2.61e-06	0.00123	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.58e-06	0.00122	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—PIK3CA—colon cancer	2.4e-06	0.00113	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PPARG—colon cancer	2.37e-06	0.00112	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.34e-06	0.00111	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.32e-06	0.0011	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—TP53—colon cancer	2.32e-06	0.0011	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—ABCB1—colon cancer	2.29e-06	0.00108	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—TYMS—colon cancer	2.25e-06	0.00106	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—HRAS—colon cancer	2.22e-06	0.00105	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PPARG—colon cancer	2.14e-06	0.00101	CbGpPWpGaD
Gadoxetate—ABCC4—Hemostasis—AKT1—colon cancer	1.96e-06	0.000927	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PTGS2—colon cancer	1.86e-06	0.000881	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.73e-06	0.000818	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PTGS2—colon cancer	1.68e-06	0.000795	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PPARG—colon cancer	1.59e-06	0.000753	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—EP300—colon cancer	1.55e-06	0.000733	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—EP300—colon cancer	1.4e-06	0.000661	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PTGS2—colon cancer	1.25e-06	0.000592	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—PIK3CA—colon cancer	1.15e-06	0.000542	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—EP300—colon cancer	1.04e-06	0.000492	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—PIK3CA—colon cancer	1.03e-06	0.000489	CbGpPWpGaD
Gadoxetate—SLCO1B3—Metabolism—AKT1—colon cancer	9.37e-07	0.000443	CbGpPWpGaD
Gadoxetate—ABCC3—Metabolism—AKT1—colon cancer	8.45e-07	0.0004	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—PIK3CA—colon cancer	7.71e-07	0.000364	CbGpPWpGaD
Gadoxetate—SLCO1B1—Metabolism—AKT1—colon cancer	6.3e-07	0.000298	CbGpPWpGaD
